News
WILYY
15.80
NaN%
--
Barclays Remains a Hold on Demant (WILLF)
TipRanks · 11/25 01:25
Demant initiated with a Sector Perform at RBC Capital
TipRanks · 11/18 16:55
Demant price target lowered to DKK 250 from DKK 267 at Morgan Stanley
TipRanks · 11/10 18:40
Morgan Stanley Sticks to Its Buy Rating for Demant (WILLF)
TipRanks · 11/10 16:35
Barclays Keeps Their Hold Rating on Demant (WILLF)
TipRanks · 11/08 01:38
Goldman Sachs Keeps Their Buy Rating on Demant (WILLF)
TipRanks · 11/06 08:35
Citi Keeps Their Buy Rating on Demant (WILLF)
TipRanks · 10/31 08:59
Demant To Sell Oticon Medical To Impilo For Up To DKK 600 Mln
NASDAQ · 10/22 07:15
Demant (WILLF) Gets a Hold from Barclays
TipRanks · 09/29 10:36
EU MedTech stocks down as U.S. launches national security probe into imports
Seeking Alpha · 09/25 11:06
Weekly Report: what happened at WILYY last week (0908-0912)?
Weekly Report · 09/15 10:58
Weekly Report: what happened at WILYY last week (0901-0905)?
Weekly Report · 09/08 11:00
Weekly Report: what happened at WILYY last week (0825-0829)?
Weekly Report · 09/01 10:56
Weekly Report: what happened at WILYY last week (0818-0822)?
Weekly Report · 08/25 11:05
Kepler Capital Keeps Their Buy Rating on Demant (WILLF)
TipRanks · 08/20 01:36
Weekly Report: what happened at WILYY last week (0811-0815)?
Weekly Report · 08/18 10:58
Kepler Capital Reaffirms Their Buy Rating on Demant (WILLF)
TipRanks · 08/15 01:46
Demant price target raised to DKK 291 from DKK 274 at JPMorgan
TipRanks · 08/14 17:15
J.P. Morgan Sticks to Their Buy Rating for Demant (WILLF)
TipRanks · 08/14 09:35
Barclays Sticks to Its Hold Rating for Demant (WILLF)
TipRanks · 08/14 06:45
More
Webull provides a variety of real-time WILYY stock news. You can receive the latest news about Demant A S through multiple platforms. This information may help you make smarter investment decisions.
About WILYY
Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.